title: New directions for drug discovery.
abstract: Modern drug discovery demands an integrative approach, using many different technologies, but ultimately based on an understanding of the pathophysiology of the disease state to be treated. Targeting drugs at the main pathophysiological process is the key to success. This issue needs to be addressed with the multiple screening systems available, which can be used to find new leads.
authors.affiliation: Experimental Sciences, Servier Research Institute, Suresnes, France. michael.spedding@fr.netgrs.com
authors.forename: Michael
authors.initials: M
authors.lastname: Spedding
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D017277:Drug Approval; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D010600:Pharmacology / Q000639:trends*; D011619:Psychotropic Drugs / Q000494:pharmacology
chemical_list: D011619:Psychotropic Drugs